GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

ReShape Lifesciences Inc. is a physician-led company specializing in weight loss and metabolic health solutions, offering products such as the FDA-approved Lap-Band® System and the investigational ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good afternoon, and welcome to Fractyl Health’s Third Quarter Financial Results and Business Updates Call. As a reminder, this conference ...

It's not just vaccine makers that are down following the announcement that former President Donald Trump has nominated Robert ...

Good afternoon, and welcome to Fractyl Health's Third Quarter Financial Results and Business Updates Call. As a reminder, this conference call is being recorded. [Operator Instructions]. I will now ...

Gilead Sciences, Inc. today announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81% (30 out of 37) of participants with primary biliary ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September ...

GLP-1 medications, like Ozempic and Wegovy, mimic natural hormones in the body that regulate blood sugar and insulin levels. They’re used to treat type 2 diabetes and obesity. These drugs curb the ...

The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...

RFK Jr., a prominent vaccine skeptic, wants to make many changes to the U.S. food and drug system as head of the HHS. Here's ...

A new study published in JAMA Psychiatry linked GLP-1 receptor agonists like Ozempic with a lower risk of alcohol-related ...